$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000093454918000043 Filed on May 10, 2018

Income Statement

Concept	2018 Q2	2018 Q1	2017 Q1
Revenue	$6.485M	$62.09M	$8.854M
YoY Change	-60.59%	601.3%	-64.18%
Cost Of Revenue	$1.240M	$21.74M	$670.0K
YoY Change	-70.96%	3144.78%	-57.32%
Gross Profit	$5.240M	$40.35M	$8.190M
YoY Change	-56.98%	392.67%	-64.62%
Gross Profit Margin	80.8%	64.98%	92.5%
Selling, General & Admin	$7.950M	$19.14M	$7.540M
YoY Change	-20.26%	153.85%	-37.69%
% of Gross Profit	151.72%	47.43%	92.06%
Research & Development		$170.0K	$320.0K
YoY Change		-46.88%	-38.46%
% of Gross Profit		0.42%	3.91%
Depreciation & Amortization	$5.300M	$5.344M	$5.540M
YoY Change	-5.36%	-3.54%	-48.72%
% of Gross Profit	101.15%	13.24%	67.64%
Operating Expenses	$13.23M	$24.63M	$13.37M
YoY Change	-17.16%	84.22%	-46.8%
Operating Profit	-$38.84M	$8.970M	-$11.58M
YoY Change	390.11%	-177.49%	19.32%
Interest Expense	$11.62M	-$40.89M
YoY Change
% of Operating Profit		-455.85%
Other Income/Expense, Net	$11.62M	-$40.89M	$696.0K
YoY Change	-338.89%	-5975.0%	-23300.0%
Pretax Income	-$28.22M	-$31.92M	-$10.88M
YoY Change	120.72%	193.38%	12.11%
Income Tax	$285.0K	$191.0K	$1.241M
% Of Pretax Income
Net Earnings	-$28.43M	-$32.04M	-$11.83M
YoY Change	99.46%	170.82%	18.72%
Net Earnings / Revenue	-438.35%	-51.6%	-133.61%
Basic Earnings Per Share		-$0.63
Diluted Earnings Per Share	-$567.9K	-$632.8K	-$235.0K
COMMON SHARES
Basic Shares Outstanding	50.65M shares	50.64M shares	50.33M shares
Diluted Shares Outstanding	50.06M shares	50.63M shares	50.33M shares

Balance Sheet

Concept	2018 Q2	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$134.8M	$179.6M	$145.2M
YoY Change	13.95%	23.69%	-0.07%
Cash & Equivalents	$100.2M	$150.3M	$65.84M
Short-Term Investments	$34.70M	$29.40M	$90.90M
Other Short-Term Assets	$3.500M	$3.800M	$16.60M
YoY Change	-14.63%	-77.11%	3.11%
Inventory
Prepaid Expenses
Receivables	$5.629M	$4.695M	$7.781M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$144.0M	$188.2M	$169.7M
YoY Change	5.38%	10.92%	-9.06%
LONG-TERM ASSETS
Property, Plant & Equipment			$94.00K
YoY Change			-59.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.195M	$8.195M	$2.200M
YoY Change	241.46%	272.5%
Other Assets	$187.0K	$1.193M	$336.0K
YoY Change	-54.05%	255.06%	-69.76%
Total Long-Term Assets	$106.5M	$129.6M	$103.2M
YoY Change	-16.72%	25.64%	-32.66%
TOTAL ASSETS
Total Short-Term Assets	$144.0M	$188.2M	$169.7M
Total Long-Term Assets	$106.5M	$129.6M	$103.2M
Total Assets	$250.5M	$317.8M	$272.9M
YoY Change	-5.3%	16.48%	-19.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.900M	$9.000M	$11.70M
YoY Change	-3.26%	-23.08%	-19.86%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.62M	$48.98M	$14.79M
YoY Change	-27.03%	231.15%	-55.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.471M	$1.805M	$380.0K
YoY Change	328.25%	375.0%	10.14%
Total Long-Term Liabilities	$2.471M	$1.805M	$380.0K
YoY Change	328.25%	375.0%	10.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.62M	$48.98M	$14.79M
Total Long-Term Liabilities	$2.471M	$1.805M	$380.0K
Total Liabilities	$16.09M	$50.78M	$15.17M
YoY Change	-16.38%	234.75%	-55.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$378.0M	-$317.5M	-$354.0M
YoY Change	2.63%	-10.31%	18.76%
Common Stock	$49.00K	$51.00K	$51.00K
YoY Change	-3.92%	0.0%	2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$39.27M	$34.64M	$34.64M
YoY Change	13.37%	0.0%	0.0%
Treasury Stock Shares	2.920M shares	1.729M shares	1.729M shares
Shareholders Equity	$232.9M	$265.5M	$256.1M
YoY Change
Total Liabilities & Shareholders Equity	$250.5M	$317.8M	$272.9M
YoY Change	-5.3%	16.48%	-19.7%

Cashflow Statement

Concept	2018 Q2	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$28.43M	-$32.04M	-$11.83M
YoY Change	99.46%	170.82%	18.72%
Depreciation, Depletion And Amortization	$5.300M	$5.344M	$5.540M
YoY Change	-5.36%	-3.54%	-48.72%
Cash From Operating Activities	-$40.40M	$49.97M	-$976.0K
YoY Change	839.53%	-5219.88%	-108.78%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$5.200M	-$36.30M	-$72.50M
YoY Change	-471.43%	-49.93%
Cash From Investing Activities	-$5.200M	-$36.31M	-$72.47M
YoY Change	-471.43%	-49.9%	7118.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$7.000K	$25.00K
YoY Change		-72.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.600M	$24.00K	$230.0K
YoY Change	-1250.0%	-89.57%
NET CHANGE
Cash From Operating Activities	-40.40M	$49.97M	-$976.0K
Cash From Investing Activities	-5.200M	-$36.31M	-$72.47M
Cash From Financing Activities	-4.600M	$24.00K	$230.0K
Net Change In Cash	-50.20M	$13.69M	-$73.22M
YoY Change	1908.0%	-118.69%	-824.48%
FREE CASH FLOW
Cash From Operating Activities	-$40.40M	$49.97M	-$976.0K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		$49.97M	-$976.0K
YoY Change		-5219.88%	-108.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	us-gaap	Minority Interest MinorityInterest	1593000	USD
CY2017Q2	actg	A10 Warrant A10Warrant	809400	shares
CY2017Q1	actg	Beneficial Ownership Percentage Limit BeneficialOwnershipPercentageLimit	0.60
CY2017Q1	actg	Bridge Installment Shares BridgeInstallmentShares	90000	shares
CY2017Q1	actg	Bridge Warrant Share BridgeWarrantShare	157000	shares
CY2017Q1	actg	Bridgeloanstatedinterestrate Bridgeloanstatedinterestrate	0.08
CY2017Q2	actg	Cashpaidforprimarywarrantexercise Cashpaidforprimarywarrantexercise	29300000	USD
CY2017Q1	actg	Contingent Legal Fees ContingentLegalFees	627000	USD
CY2018Q1	actg	Contingent Legal Fees ContingentLegalFees	15759000	USD
CY2018Q1	actg	Cumulative Unrealized Gain Loss Since Inception CumulativeUnrealizedGainLossSinceInception	8429000	USD
CY2018Q1	actg	Fair Valueof Profits Interest FairValueofProfitsInterest	1313000	USD
CY2017Q1	actg	Fair Valueof Profits Interest FairValueofProfitsInterest	722000	USD
CY2016Q3	actg	First Loan Warrant FirstLoanWarrant	700000	USD
CY2017Q1	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	4788000	USD
CY2018Q1	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	4403000	USD
CY2017Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-10830000	USD
CY2018Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	36608000	USD
CY2017	actg	Investmentin Miso Robotics InvestmentinMisoRobotics	2250000	USD
CY2018Q1	actg	Investmentin Miso Robotics InvestmentinMisoRobotics	6000000	USD
CY2017Q4	actg	Investmentincommonstock Investmentincommonstock	90795000	USD
CY2018Q1	actg	Investmentincommonstock Investmentincommonstock	57345000	USD
CY2018Q1	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	-1728000	USD
CY2014	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	6	patent_portfolios
CY2015	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	3	patent_portfolios
CY2017Q4	actg	Investmentsatfairvalue Investmentsatfairvalue	104754000	USD
CY2018Q1	actg	Investmentsatfairvalue Investmentsatfairvalue	63657000	USD
CY2017Q4	actg	Investmentwarrants Investmentwarrants	13959000	USD
CY2018Q1	actg	Investmentwarrants Investmentwarrants	6312000	USD
CY2017Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	6386000	USD
CY2018Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	2745000	USD
CY2016Q3	actg	Maximum Investmentin Veritone MaximumInvestmentinVeritone	50000000	USD
CY2017Q1	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	2112000	USD
CY2018Q1	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	704000	USD
CY2017Q1	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	16000	USD
CY2016	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	2	patent_portfolios
CY2017	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	1	patent_portfolios
CY2017Q4	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	382220000	USD
CY2018Q1	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	387550000	USD
CY2017Q4	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	61917000	USD
CY2018Q1	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	56587000	USD
CY2017Q4	actg	Percentageofownership Miso Robotics PercentageofownershipMisoRobotics	0.226
CY2018Q1	actg	Percentageofownership Miso Robotics PercentageofownershipMisoRobotics	0.30
CY2017Q2	actg	Percentageofownership Veritone PercentageofownershipVeritone	0.2
CY2017Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	320000	USD
CY2018Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	166000	USD
CY2017Q1	actg	Revenues Paidup RevenuesPaidup	7196000	USD
CY2018Q1	actg	Revenues Paidup RevenuesPaidup	60063000	USD
CY2017Q1	actg	Revenues Salesbased RevenuesSalesbased	1658000	USD
CY2018Q1	actg	Revenues Salesbased RevenuesSalesbased	2030000	USD
CY2017Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	1601000	USD
CY2018Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	39937000	USD
CY2018Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	3329000	USD
CY2016Q3	actg	Secured Convertible Promissory Note SecuredConvertiblePromissoryNote	20000000	USD
CY2016Q3	actg	Secured Promissory Note Advance SecuredPromissoryNoteAdvance	10000000	USD
CY2018Q1	actg	Unrealized Gain Losson Investment Warrants UnrealizedGainLossonInvestmentWarrants	-7647000	USD
CY2018Q1	actg	Unrealized Gain Losson Investments Common Stock UnrealizedGainLossonInvestmentsCommonStock	-33450000	USD
CY2017Q1	actg	Upfront Shares UpfrontShares	60000	shares
CY2017Q1	actg	Veritone Bridge Loan Advance1 VeritoneBridgeLoanAdvance1	1000000	USD
CY2017Q1	actg	Veritone Bridge Loan Advance3and4 VeritoneBridgeLoanAdvance3and4	2000000	USD
CY2016Q3	actg	Veritone Primary Warrant VeritonePrimaryWarrant	50000000	USD
CY2017Q4	actg	Writedownofdeferredtaxassets Writedownofdeferredtaxassets	25261000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50647882	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7956000	USD
CY2018Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9040000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	153000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4754000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4695000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	369000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-88000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-125000	USD
CY2018Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	648996000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	649724000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5515000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5330000	USD
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4420717	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5898369	shares
CY2017Q4	us-gaap	Assets Assets	308768000	USD
CY2018Q1	us-gaap	Assets Assets	317835000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	139695000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	188203000	USD
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29359000	USD
CY2018Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	29378000	USD
CY2018Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
CY2018Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	19000	USD
CY2017Q1	us-gaap	Bridge Loan BridgeLoan	4000000	USD
CY2017Q2	us-gaap	Bridge Loan BridgeLoan	4000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139052000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65836000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	136604000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	150289000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-73216000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13685000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50639926	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50647882	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50639926	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50647882	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11803000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32075000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12094000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32148000	USD
CY2017Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	13.6088
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5540000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5344000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.63
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.11
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.23
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2195000	USD
CY2018Q1	us-gaap	Equity Method Investments EquityMethodInvestments	8195000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6197000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	15212000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5256000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5261000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6134000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	18527000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	56587000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6916000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3379000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10880000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31920000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1241000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2576000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1065000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18969000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1738000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	863000	USD
CY2017Q1	us-gaap	Interest Income Other InterestIncomeOther	1000000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	13109000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	50782000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	308768000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	317835000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9557000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	48977000	USD
CY2017Q1	us-gaap	Licenses Revenue LicensesRevenue	8854000	USD
CY2018Q1	us-gaap	Licenses Revenue LicensesRevenue	62093000	USD
CY2017Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	20700000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	1358000	USD
CY2018Q1	us-gaap	Minority Interest MinorityInterest	1666000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	230000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72470000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36309000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-976000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49970000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-11830000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-32038000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-291000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-73000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11830000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-32038000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	696000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-40890000	USD
CY2017Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	20430000	USD
CY2018Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	53123000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11576000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8970000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	207000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1193000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	13000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-17000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-20000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2017Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	0	USD
CY2018Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	4000000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3552000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1805000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	696000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	207000	USD
CY2017Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-348000	USD
CY2018Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-87000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	174152000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	33309000	USD
CY2017Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	USD
CY2018Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2017Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
CY2018Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	7000000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2938000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3801000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	102682000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	4000000	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	255000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	31000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-12121000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-32111000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320018000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-349550000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-317512000	USD
CY2017Q1	us-gaap	Revenues Revenues	8854000	USD
CY2018Q1	us-gaap	Revenues Revenues	62093000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	267053000	USD
CY2017Q1	us-gaap	Royalty Expense RoyaltyExpense	666000	USD
CY2018Q1	us-gaap	Royalty Expense RoyaltyExpense	21744000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2128000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-1024000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2018Q1	us-gaap	Short Term Investments ShortTermInvestments	29359000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	294301000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	265460000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	295659000	USD
CY2016Q3	us-gaap	Timesharing Transactions Stated Interest Rate For Notes Receivable TimesharingTransactionsStatedInterestRateForNotesReceivable	0.06
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2018Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2018Q1	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2017Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2018Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-41097000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50333056	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50632958	shares
CY2018Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">One</font><font style="font-family:inherit;font-size:10pt;"> licensee individually accounted for </font><font style="font-family:inherit;font-size:10pt;">96%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, and two licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">73%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended March 31, 2017. For the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and 2017, </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">92%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. Two licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2017. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name	View Source	Status
0000934549-18-000043-index-headers.html	Edgar Link	pending
0000934549-18-000043-index.html	Edgar Link	pending
0000934549-18-000043.txt	Edgar Link	pending
0000934549-18-000043-xbrl.zip	Edgar Link	pending
actg-20180331.xml	Edgar Link	completed
actg-20180331.xsd	Edgar Link	pending
actg-20180331_cal.xml	Edgar Link	unprocessable
actg-20180331_def.xml	Edgar Link	unprocessable
actg-20180331_lab.xml	Edgar Link	unprocessable
actg-20180331_pre.xml	Edgar Link	unprocessable
actg10q03312018.htm	Edgar Link	pending
ex31103312018.htm	Edgar Link	pending
ex31203312018.htm	Edgar Link	pending
ex32103312018.htm	Edgar Link	pending
ex32203312018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graphicactga02a09.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2018 Q2 Form 10-Q Financial Statement

#000093454918000043 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2018 Q2 Form 10-Q Financial Statement

#000093454918000043 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg